Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPOWER: Empagliflozin and Metformin on Skeletal Muscle in Type 2 Diabetes
NCT07771010Phase 4Recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in type 2 diabetes mellitus (T2DM), sponsored by University Medical Centre Ljubljana. Started Apr 2026; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07771010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07771010.